Medycyna - Farmaceutyka - Ochrona zdrowia
Doświadczenie w pracy:
LIQVOR PHARMACEUTICALS (ARMENIA) 12/2022 - PRESENT
Chemist analyst. R&D department.
Developed an analytical method for hyaluronic acid.
Validated the method of flame spectrophotometer.
R-PHARM GROUP 12/2021 - 03/2022
Chemist analyst / QC Chemist. Analytical Laboratory / Quality Control
Department.
Carrying out input control of raw materials, interoperational control, as well
as vaccines Sputnik-V.
Carried out the transfer of analytical methods for the «Remdesivir» project.
Wrote 4 methods for operating on HPLC.
Developed methods for quality control of plastic disposable systems.
NOVAMEDICA INNOTECH 12/2020 - 11/2021
Chemist analyst. R&D department.
Development of a regulatory document.
Development of HPLC Analytical Methods.
Worked with analytical equipment HPLC, GC, UV, IR, flame
spectrophotometer, Refractometer, Fischer aquametry polarimeter.
Validation of analytical methods.
Developed 8 drugs: Dexibuprofen, Rebamipide, Telmisartan, Deferasirox,
Tretinoin, Moxonidine, Gabapentin, Benfotiamine and etc.
Edukacja:
RUSSIAN PRESIDENTIAL ACADEMY OF NATIONAL ECONOMY 2021 - 2025
AND PUBLIC ADMINISTRATION
B.Sc. State and municipal administration.
PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL 2018 - 2021
UNIVERSITY
PhD student / h-index 1. Medical-biology. Pharmacology and clinical
pharmacology
TVER STATE MEDICAL UNIVERSITY 2013 - 2018
Specialist degree. Pharmacy. Pharmacist
Umiejętności zawodowe i inne:
HPLC:
I can work on HPLC Agilent, Shimadzu, Waters and UPLC Perkin Elmer
Cell technology:
Isolate of primary cell culture, cultivation of lines, immortalization of primary cultures.
Cryopreservation, cultivation of prokaryotic cells (E. coli, B. subtillis)
Molecular biological methods:
Light and fluorescent microscopy, RT PCR, MTT, Alamar Blue,
Immunoblotting, isolate of plasmids.
Dodatkowo:
SCIENTIFIC ARTICLE IN CHEMISTRYSELECT JOURNAL
A Pregnane Steroid as the Chiral Auxiliary in 1,3-Dipolar Azomethine Ylide's
Cycloaddition: Asymmetric Synthesis and Anticancer Activity of Novel Hybrid
Compounds
SCIENTIFIC ARTICLE IN PHARMACEUTICAL CHEMISTRY JOURNAL
Metabolic Enzymes: New Targets for the Design of Antitumor Drugs